| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.56▼ | 1.54▲ | 1.54▲ | 1.52▲ | 1.67▼ |
| MA10 | 1.52▲ | 1.51▲ | 1.51▲ | 1.56▲ | 1.75▼ |
| MA20 | 1.52▲ | 1.52▲ | 1.53▲ | 1.65▼ | 1.95▼ |
| MA50 | 1.58▼ | 1.62▼ | 1.64▼ | 1.78▼ | 1.94▼ |
| MA100 | 1.67▼ | 1.70▼ | 1.70▼ | 1.97▼ | 2.07▼ |
| MA200 | 1.70▼ | 1.83▼ | 1.89▼ | 1.90▼ | 4.27▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.014▲ | 0.014▲ | 0.014▲ | -0.005▼ | -0.051▼ |
| RSI | 51.060▲ | 49.721▼ | 48.429▼ | 44.553▼ | 40.330▼ |
| STOCH | 95.833▲ | 84.722▲ | 81.944▲ | 39.180 | 16.756▼ |
| WILL %R | -20.000▲ | -20.000▲ | -33.333 | -50.000 | -84.000▼ |
| CCI | 70.000 | 83.854 | 67.919 | -37.412 | -95.363 |
|
Wednesday, August 08, 2018 06:30 PM
Affimed Therapeutics (NASDAQ:AFMD) Q2 2018 Results Earnings Conference Call August 7, 2018 8:30 AM ET Executives Greg Gin - Head of Investor Relations Adi Hoess - Chief Executive Officer Florian Fisch...
|
|
Wednesday, August 08, 2018 04:31 AM
Heidelberg, Germany, August 8, 2018 - Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies that harness ...
|
|
Friday, August 03, 2018 10:06 AM
About Affimed N.V. Affimed (Nasdaq: AFMD) engineers targeted immunotherapies, seeking to cure patients by harnessing the power of innate and adaptive immunity (NK and T cells). We are developing singl...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 17/08/18 | 1.50 | 1.60 | 1.50 | 1.60 | 137,325 |
| 16/08/18 | 1.50 | 1.55 | 1.475 | 1.50 | 328,576 |
| 15/08/18 | 1.45 | 1.50 | 1.45 | 1.50 | 207,742 |
| 14/08/18 | 1.55 | 1.60 | 1.40 | 1.45 | 209,560 |
| 13/08/18 | 1.60 | 1.6422 | 1.55 | 1.55 | 100,759 |
| 10/08/18 | 1.5528 | 1.60 | 1.40 | 1.60 | 534,695 |
| 09/08/18 | 1.65 | 1.65 | 1.55 | 1.60 | 232,488 |
| 08/08/18 | 1.60 | 1.65 | 1.5742 | 1.625 | 105,829 |
| 07/08/18 | 1.65 | 1.70 | 1.55 | 1.55 | 394,366 |
| 06/08/18 | 1.65 | 1.70 | 1.575 | 1.65 | 385,482 |
|
|
||||
|
|
||||
|
|
||||
|
|